ストックスクリーナーアプリを入手
1.68
0.00%
0.00
プレマーケット:
1.63
-0.05
-2.98%
前日終値:
$1.68
開ける：
$1.66
24時間の取引高:
181.00K
Relative Volume:
0.14
時価総額：
$215.48M
収益：
$272.07M
当期純損益:
$-248.06M
株価収益率:
-0.833
EPS:
-2.0167
ネットキャッシュフロー:
$-16.48M
1週間 パフォーマンス:
+12.00%
1か月 パフォーマンス:
-2.33%
6か月 パフォーマンス:
+7.69%
1年 パフォーマンス:
-40.43%
1日の値動き範囲:
$1.64
$1.70
1週間の範囲:
$1.55
$1.85
52週間の値動き範囲:
$0.72
$3.22
Waldencast Plc Stock (WALD) Company Profile
名前
Waldencast Plc
電話
(917) 546-6828
住所
10 BANK STREET, SUITE 560, WHITE PLAINS
Compare WALD vs PG, UL, CL, KVUE, KMB
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
WALD
Waldencast Plc
|
1.68 | 225.74M | 272.07M | -248.06M | -16.48M | -2.0167 |
PG
Procter Gamble Co
|
149.31 | 341.47B | 86.72B | 16.69B | 15.03B | 6.8375 |
UL
Unilever Plc Adr
|
61.58 | 129.46B | 56.67B | 6.96B | 7.39B | 3.1265 |
CL
Colgate Palmolive Co
|
93.39 | 73.36B | 20.80B | 2.22B | 3.77B | 2.5772 |
KVUE
Kenvue Inc
|
19.56 | 36.69B | 15.29B | 1.62B | 1.82B | 0.8433 |
KMB
Kimberly Clark Corp
|
113.01 | 36.44B | 16.56B | 1.75B | 1.84B | 6.36 |
Waldencast Plc Stock (WALD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-14 | 再開されました | Jefferies | Buy |
| 2025-11-25 | ダウングレード | Telsey Advisory Group | Outperform → Market Perform |
| 2025-04-22 | 開始されました | Alliance Global Partners | Buy |
| 2024-12-16 | 開始されました | TD Cowen | Hold |
| 2024-10-25 | 開始されました | Canaccord Genuity | Buy |
| 2024-05-01 | 繰り返されました | Telsey Advisory Group | Outperform |
| 2023-07-24 | ダウングレード | Raymond James | Outperform → Mkt Perform |
すべてを表示
Waldencast Plc (WALD) 最新ニュース
Waldencast plc Warrant Financial Disclosures & SEC Filings - TradingView
Croma-Pharma Announces FDA Approval of Obagi saypha® ChIQ™ in the United States - Via TT
Price to earnings forward of Waldencast plc – NASDAQ:WALDW - TradingView
Waldencast plc Class A Actuals & Estimates (BOATS:WALD) - TradingView
Price to book forward of Waldencast plc – NASDAQ:WALDW - TradingView
Waldencast PLC (WALDW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Form 13D/A Waldencast plc For: 26 June By Investing.com - Investing.com South Africa
Major Waldencast (WALD) holder reports 0% stake after distributing 9.3M shares - Stock Titan
Waldencast PLC (WALD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Waldencast plc Class A Actuals & Estimates (NASDAQ:WALD) - TradingView
WALD Forecast — Price Target — Prediction for 2027 - TradingView
Form 13G Waldencast plc For: 23 June By Investing.com - Investing.com South Africa
Santa Venerina holds 15M Waldencast shares (WALD) via in‑kind distribution - Stock Titan
Waldencast Company Profile & Introduction - Moomoo
Waldencast PLC (WALDW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Waldencast PLC (WALD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Waldencast PLC (WALD) Institutional Confidence - TradingKey
Waldencast PLC (WALD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Waldencast PLC (WALD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Waldencast PLC (WALDW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Waldencast PLC (WALDW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Waldencast PLC (WALD) Valuation: PE, PB & Fair Value Analysis - TradingKey
Waldencast PLC (WALDW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Waldencast PLC (WALDW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Waldencast PLC (WALD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Waldencast PLC (WALD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Waldencast PLC (WALD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Waldencast PLC (WALDW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Waldencast PLC (WALDW) Institutional Confidence - TradingKey
Waldencast PLC (WALDW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Waldencast Delays Warrant Issuance to November as Obagi Wins FDA Nod for saypha ChIQ - The Globe and Mail
FDA approves Obagi saypha ChIQ filler from Waldencast (NASDAQ: WALD) - Stock Titan
Waldencast receives FDA approval for Obagi saypha ChIQ filler By Investing.com - Investing.com Australia
Waldencast receives FDA approval for Obagi saypha ChIQ filler - Investing.com
WALD Q4 2024 Earnings: Significant EPS Miss on Low ExpectationsProfit Margin Analysis - newsline.com
FDA approves Obagi cheek-augmentation filler for midface contour issues - Stock Titan
Obagi Medical Announces FDA Approval of Obagi® saypha® ChIQ™ Injectable Hyaluronic Acid Gel - GlobeNewswire
Waldencast Q4 2024 Earnings: EPS Misses Estimates Amidst Challenging QuarterPost-Earnings Drift - newsline.com
WALD Q4 2024 Earnings: Significant EPS Miss Raises Concerns Amidst Growth StrategyDividend Growth Analysis - newsline.com
Waldencast plc (WALD) Q4 2024 Earnings: Significant EPS Miss Highlights Profitability PressuresShare Dilution Risk - newsline.com
Latham Advises Bridgepoint in Acquisition of Obagi Medical From Waldencast - Latham & Watkins LLP
Canaccord raises Waldencast stock price target on Obagi sale By Investing.com - Investing.com Australia
Canaccord raises Waldencast stock price target on Obagi sale - Investing.com
WALD ALERT: Hagens Berman, National Trial Attorneys, Encourages Waldencast plc (WALD) Investors with Substantial Losses to Contact Firm's Attorneys, Firm Investigating Possible Securities Law Violations - TMX Newsfile
Obagi Medical sold to Bridgepoint as Waldencast focuses on Milk Makeup brand - FashionNetwork France
Waldencast Announces Sale of Obagi Medical To Bridgepoint - Happi | Household And Personal Products Industry
Waldencast agrees to sell Obagi Medical for up to $460 million By Investing.com - Investing.com India
Waldencast to Sell Obagi Medical to Bridgepoint for Up to $460 Million and Refocus on Milk Makeup - TipRanks
Waldencast plc Announces CEO Changes - marketscreener.com
Obagi sale lets Waldencast (NASDAQ: WALD) cut debt and focus Milk - Stock Titan
Waldencast Announces Sale of Obagi Medical to Bridgepoint - The Manila Times
Waldencast Plc (WALD) 財務データ
収益
当期純利益
現金流量
EPS
1.41%
3.83%
大文字化:
|
ボリューム (24 時間):